Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Betahistine market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Betahistine market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
8mg
25mg
Others
Segmented by End User/Segment
Cerebral Thrombosis
Cerebral Embolism
Others
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
TOWA PHARMACEUTICAL CO., LTD
Takeda Pharmaceutical Company Limited
Orion Corporation
Nichi-Iko Pharmaceutical
Mylan
HENNIG ARZNEIMITTEL GmbH & Co. KG
EA Pharma Co., Ltd.
DOC Generici
Disphar International B.V.
Ciclum Farma Unipessoal
Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Betahistine Market Status and Forecast (2016-2027) 1.3.2 Global Betahistine Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Betahistine Supply by Company 2.1 Global Betahistine Sales Volume by Company 2.2 Global Betahistine Sales Value by Company 2.3 Global Betahistine Price by Company 2.4 Betahistine Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional Betahistine Market Status by Category 3.1 Betahistine Category Introduction 3.1.1 8mg 3.1.2 25mg 3.1.3 Others 3.2 Global Betahistine Market by Category 3.2.1 Global Betahistine Sales Volume by Category (2016-2021) 3.2.2 Global Betahistine Sales Value by Category (2016-2021) 3.2.3 Global Betahistine Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Betahistine Market Status by End User/Segment 4.1 Betahistine Segment by End User/Segment 4.1.1 Cerebral Thrombosis 4.1.2 Cerebral Embolism 4.1.3 Others 4.2 Global Betahistine Market by End User/Segment 4.2.1 Global Betahistine Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Betahistine Sales Value by End User/Segment (2016-2021) 4.2.3 Global Betahistine Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Betahistine Market Status by Region 5.1 Global Betahistine Market by Region 5.1.1 Global Betahistine Sales Volume by Region 5.1.2 Global Betahistine Sales Value by Region 5.2 North America Betahistine Market Status 5.3 Europe Betahistine Market Status 5.4 Asia Pacific Betahistine Market Status 5.5 Central & South America Betahistine Market Status 5.6 Middle East & Africa Betahistine Market Status6 North America Betahistine Market Status 6.1 North America Betahistine Market by Country 6.1.1 North America Betahistine Sales Volume by Country (2016-2021) 6.1.2 North America Betahistine Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Betahistine Market Status 7.1 Europe Betahistine Market by Country 7.1.1 Europe Betahistine Sales Volume by Country (2016-2021) 7.1.2 Europe Betahistine Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Betahistine Market Status 8.1 Asia Pacific Betahistine Market by Country 8.1.1 Asia Pacific Betahistine Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Betahistine Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Betahistine Market Status 9.1 Central & South America Betahistine Market by Country 9.1.1 Central & South America Betahistine Sales Volume by Country (2016-2021) 9.1.2 Central & South America Betahistine Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Betahistine Market Status 10.1 Middle East & Africa Betahistine Market by Country 10.1.1 Middle East & Africa Betahistine Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Betahistine Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Betahistine Manufacturing Cost Analysis 11.5 Betahistine Sales Channel and Distributors Analysis 11.5.1 Betahistine Sales Channel 11.5.2 Betahistine Distributors 11.6 Betahistine Downstream Major Buyers12 Global Betahistine Market Forecast by Category and by End User/Segment 12.1 Global Betahistine Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Betahistine Forecast by Category 12.2.1 Global Betahistine Sales Volume Forecast by Category 12.2.2 Global Betahistine Sales Value Forecast by Category 12.2.3 Global Betahistine Price Forecast by Category 12.3 Global Betahistine Forecast by End User/Segment 12.3.1 Global Betahistine Sales Volume Forecast by End User/Segment 12.3.2 Global Betahistine Sales Value Forecast by End User/Segment 12.3.3 Global Betahistine Price Forecast by End User/Segment13 Global Betahistine Market Forecast by Region/Country 13.1 Global Betahistine Market Forecast by Region (2022-2027) 13.1.1 Global Betahistine Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Betahistine Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 TOWA PHARMACEUTICAL CO., LTD 14.1.1 Company Information 14.1.2 Betahistine Product Introduction 14.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Takeda Pharmaceutical Company Limited 14.2.1 Company Information 14.2.2 Betahistine Product Introduction 14.2.3 Takeda Pharmaceutical Company Limited Betahistine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Orion Corporation 14.3.1 Company Information 14.3.2 Betahistine Product Introduction 14.3.3 Orion Corporation Betahistine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Nichi-Iko Pharmaceutical 14.4.1 Company Information 14.4.2 Betahistine Product Introduction 14.4.3 Nichi-Iko Pharmaceutical Betahistine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Mylan 14.5.1 Company Information 14.5.2 Betahistine Product Introduction 14.5.3 Mylan Betahistine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 HENNIG ARZNEIMITTEL GmbH & Co. KG 14.6.1 Company Information 14.6.2 Betahistine Product Introduction 14.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 EA Pharma Co., Ltd. 14.7.1 Company Information 14.7.2 Betahistine Product Introduction 14.7.3 EA Pharma Co., Ltd. Betahistine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 DOC Generici 14.8.1 Company Information 14.8.2 Betahistine Product Introduction 14.8.3 DOC Generici Betahistine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 Disphar International B.V. 14.9.1 Company Information 14.9.2 Betahistine Product Introduction 14.9.3 Disphar International B.V. Betahistine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Ciclum Farma Unipessoal 14.10.1 Company Information 14.10.2 Betahistine Product Introduction 14.10.3 Ciclum Farma Unipessoal Betahistine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis15 Conclusion16 Methodology